Abstract
Cetuximab (CET) is a potent inhibitor of the epidermal growth factor receptor and has been shown to have activity in squamous cell carcinoma of the head and neck (SCCHN). We conducted a single-arm phase II trial of a combination therapy comprising cisplatin (CIS), CET and hyperfractionated accelerated radiotherapy (HART). Patients with UICC stage III or IVA/B, M0 SCCHN were enrolled and treated with an initial dose of CET (400 mg/m2) and then with a weekly dosage of 250 mg/m2 during HART. HART was started with a prescribed dosage of 2.0 Gy per day for 3 weeks, followed by 1.4 Gy twice daily to a total dose of 70.6 Gy to the gross tumour volume. CIS (40 mg/m2) was administered weekly (days 1, 8, 15, 22, 29 and 36). The primary objective of the phase II study was to determine the 2‑year progression-free survival (PFS). Between November 2007 and November 2010, a total of 74 patients were enrolled in the study, of whom 65 were evaluable (83% were men). Median age was 56 years (range 37-69 years). An Oropharyngeal primary tumour was diagnosed in 49%, T4a,b in 65% and N2/3 in 96% of the patients. Of these patients, 85% were smokers or ex-smokers. Complete remission (CR) was observed in 23 patients (35%). The most common toxicity grad...Continue Reading
References
Jan 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul M WeinbergerAmanda Psyrri
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David G PfisterMichael J Zelefsky
Sep 5, 2006·Lancet·Jean BourhisUNKNOWN Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Desmond CurranJames A Bonner
Sep 6, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BernierK K Ang
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Apr 30, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T KuhntJ Dunst
Sep 11, 2010·Cancer·Johnny KaoStuart H Packer
May 24, 2011·International Journal of Radiation Oncology, Biology, Physics·Mohan SuntharalingamKevin J Cullen
Jan 1, 2013·American Journal of Clinical Oncology·Ariel BirnbaumHoward Safran
Feb 6, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G FuryD G Pfister
Aug 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ann Marie EgloffArlene A Forastiere
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Kian AngRita S Axelrod
Sep 26, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Gregor HeiduschkaEdgar Selzer
May 26, 2015·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Nicolas DornoffPanagiotis Balermpas
Dec 30, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David I RosenthalJames A Bonner
May 8, 2016·Cancer Chemotherapy and Pharmacology·Goshi NishimuraNobuhiko Oridate
Jun 2, 2016·Oncology·Bhawna GuptaNarinder Kumar
Mar 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M G FuryD G Pfister
Citations
Oct 6, 2019·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Jan HaussmannChristiane Matuschek
Apr 21, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Sylvia GruberWolfgang Dörr
Feb 12, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rainer FietkauUNKNOWN PacCis-Study Group